Acquisition History / Boston Scientific / SoniVie
Boston Scientific Acquires SoniVie
Announced March 3, 2025 — $540M
What happened
SoniVie is an Israeli medtech developing an ultrasound-based hypertension treatment. Boston Scientific agreed to acquire it for up to US$540M.
- Acquirer
- Boston Scientific
- Target
- SoniVie
- Announced
- March 3, 2025
- Price
- $540M
- Industry
- Hypertension treatment devices
- Buyer type
- Strategic acquirer
- Status
- Announced, not yet closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Boston Scientific acquire SoniVie?
Boston Scientific acquired SoniVie on March 3, 2025. This was Boston Scientific's 1st publicly tracked acquisition out of 1 we have on record.
How much did Boston Scientific pay for SoniVie?
Boston Scientific paid $540M for SoniVie.
What does SoniVie do?
SoniVie is an Israeli medtech developing an ultrasound-based hypertension treatment. Boston Scientific agreed to acquire it for up to US$540M.
What other Hypertension treatment devices companies has Boston Scientific acquired?
SoniVie is Boston Scientific's only publicly tracked acquisition in Hypertension treatment devices so far.